Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EW.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EW.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EW.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBPORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBPNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
BN.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.277ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.277ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.277NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-4348.25US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used